{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:30:10Z","timestamp":1791412210238,"version":"4.3.3"},"publisher-location":"Cham","reference-count":89,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030143657","type":"print"},{"value":"9783030143664","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-14366-4_12","type":"book-chapter","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T09:04:03Z","timestamp":1558947843000},"page":"201-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Ovarian Cancer Stem Cell Heterogeneity"],"prefix":"10.1007","author":[{"given":"Jiri","family":"Hatina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieghart","family":"Sopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kripnerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain G.","family":"Zeimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"65","key":"12_CR1","doi-asserted-by":"crossref","first-page":"108316","DOI":"10.18632\/oncotarget.22718","volume":"8","author":"EK Adler","year":"2017","unstructured":"Adler EK, Corona RI, Lee JM, Rodriguez-Malave N, Mhawech-Fauceglia P, Sowter H, Hazelett DJ, Lawrenson K, Gayther SA (2017) The PAX8 cistrome in epithelial ovarian cancer. Oncotarget 8(65):108316\u2013108332","journal-title":"Oncotarget"},{"key":"12_CR201","doi-asserted-by":"crossref","unstructured":"Agnes A, Biondi A, Ricci R, Gallotta V, D\u2019Ugo D, Persiani R (2017) Krukenberg tumors: seed, route and soil. Surg Oncol 26(4):438\u2013445","DOI":"10.1016\/j.suronc.2017.09.001"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semcancer.2018.10.002","volume":"53","author":"N Ahmed","year":"2018","unstructured":"Ahmed N, Escalona R, Leung D, Chan E, Kannourakis G (2018) Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells. Semin Cancer Biol 53:265\u2013281","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"12_CR3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Chen R, Fu H-H, Montagna M, Schwartz PE, Rutherford T, Silasi D-A, Steffensen KD, Waldstrom M, Visintin I, Mor G (2009) Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8(1):158\u2013166","journal-title":"Cell Cycle"},{"issue":"21\u201322","key":"12_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10354-014-0323-8","volume":"164","author":"S Aust","year":"2014","unstructured":"Aust S, Pils D (2014) Epithelial ovarian cancer - more data, more questions? Wien Med Wochenschr 164(21\u201322):479\u2013486","journal-title":"Wien Med Wochenschr"},{"issue":"58","key":"12_CR5","doi-asserted-by":"crossref","first-page":"97851","DOI":"10.18632\/oncotarget.18415","volume":"8","author":"S Avril","year":"2017","unstructured":"Avril S, Dincer Y, Malinowsky K, Wolff C, G\u00fcndisch S, Hapfelmeier A, Boxberg M, Bronger H, Becker K-F, Schmalfeldt B (2017) Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients. Oncotarget 8(58):97851\u201397861","journal-title":"Oncotarget"},{"issue":"6","key":"12_CR6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","volume":"9","author":"RC Bast","year":"2009","unstructured":"Bast RC, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9(6):415\u2013428","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"12_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1933719114542021","volume":"22","author":"J Belotte","year":"2015","unstructured":"Belotte J, Fletcher NM, Alexis M, Morris RT, Munkarah AR, Diamond MP, Saed GM (2015) Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer. Reprod Sci 22(1):38\u201346","journal-title":"Reprod Sci"},{"issue":"1","key":"12_CR8","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/REP-14-0220","volume":"149","author":"D Bhartiya","year":"2015","unstructured":"Bhartiya D, Singh J (2015) FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure, aging, and cancer. Reproduction 149(1):R35\u2013R48","journal-title":"Reproduction"},{"issue":"6","key":"12_CR9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cyto.a.22038","volume":"81","author":"M Boesch","year":"2012","unstructured":"Boesch M, Reimer D, Rumpold H, Zeimet AG, Sopper S, Wolf D (2012) DyeCycle violet used for side population detection is a substrate of P-glycoprotein. Cytometry A 81(6):517\u2013522","journal-title":"Cytometry A"},{"issue":"16","key":"12_CR10","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.18632\/oncotarget.2053","volume":"5","author":"M Boesch","year":"2014","unstructured":"Boesch M, Zeimet AG, Reimer D, Schmidt S, Gastl G, Parson W, Spoeck F, Hatina J, Wolf D, Sopper S (2014) The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics. Oncotarget 5(16):7027\u20137039","journal-title":"Oncotarget"},{"issue":"2","key":"12_CR11","first-page":"276","volume":"1866","author":"M Boesch","year":"2016","unstructured":"Boesch M, Sopper S, Zeimet AG, Reimer D, Gastl G, Ludewig B, Wolf D (2016a) Heterogeneity of cancer stem cells: rationale for targeting the stem cell niche. Biochim Biophys Acta 1866(2):276\u2013289","journal-title":"Biochim Biophys Acta"},{"issue":"3\u20134","key":"12_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18632\/oncoscience.300","volume":"3","author":"M Boesch","year":"2016","unstructured":"Boesch M, Zeimet AG, Fiegl H, Wolf B, Huber J, Klocker H, Gastl G, Sopper S, Wolf D (2016b) High prevalence of side population in human cancer cell lines. Oncoscience 3(3\u20134):85\u201387","journal-title":"Oncoscience"},{"issue":"4","key":"12_CR13","doi-asserted-by":"crossref","first-page":"e1414129","DOI":"10.1080\/2162402X.2017.1414129","volume":"7","author":"M Boesch","year":"2018","unstructured":"Boesch M, Onder L, Cheng H-W, Novkovic M, M\u00f6rbe U, Sopper S, Gastl G, Jochum W, Ruhstaller T, Knauer M, Ludewig B (2018a) Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. Oncoimmunology 7(4):e1414129","journal-title":"Oncoimmunology"},{"key":"12_CR013","doi-asserted-by":"crossref","unstructured":"Boesch M, Reimer D, Sopper S, Wolf D, Zeimet AG (2018b) (Iso-)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer. Oncologist 23(7):757\u2013759.","DOI":"10.1634\/theoncologist.2017-0683"},{"issue":"5","key":"12_CR14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1158\/1541-7786.MCR-08-0401","volume":"7","author":"DM Brantley-Sieders","year":"2009","unstructured":"Brantley-Sieders DM, Zhuang G, Vaught D, Freeman T, Hwang Y, Hicks D, Chen J (2009) Host deficiency in Vav2\/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo. Mol Cancer Res 7(5):615\u2013623","journal-title":"Mol Cancer Res"},{"issue":"7440","key":"12_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature11962","volume":"495","author":"JD Brenton","year":"2013","unstructured":"Brenton JD, Stingl J (2013) Stem cells: anatomy of an ovarian cancer. Nature 495(7440):183\u2013184","journal-title":"Nature"},{"issue":"24","key":"12_CR16","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519\u20132529","journal-title":"N Engl J Med"},{"issue":"9","key":"12_CR17","doi-asserted-by":"crossref","first-page":"R411","DOI":"10.1530\/ERC-16-0209","volume":"23","author":"C Cardenas","year":"2016","unstructured":"Cardenas C, Alvero AB, Yun BS, Mor G (2016) Redefining the origin and evolution of ovarian cancer: a hormonal connection. Endocr Relat Cancer 23(9):R411\u2013R422","journal-title":"Endocr Relat Cancer"},{"key":"12_CR18","volume-title":"StemBook","author":"HL Chang","year":"2008","unstructured":"Chang HL, MacLaughlin DT, Donahoe PK (2008) Somatic stem cells of the ovary and their relationship to human ovarian cancers. In: StemBook. Harvard Stem Cell Institute, Cambridge"},{"issue":"2","key":"12_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/cbt.22959","volume":"14","author":"L Coffman","year":"2013","unstructured":"Coffman L, Mooney C, Lim J, Bai S, Silva I, Gong Y, Yang K, Buckanovich RJ (2013) Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells. Cancer Biol Ther 14(2):184\u2013192","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"12_CR20","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/cncr.20211","volume":"100","author":"J Cortes","year":"2004","unstructured":"Cortes J, Kantarjian H (2004) Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders. Cancer 100(10):2064\u20132078","journal-title":"Cancer"},{"issue":"4","key":"12_CR21","first-page":"717","volume":"71","author":"DW Cramer","year":"1983","unstructured":"Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71(4):717\u2013721","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"12_CR22","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","volume":"27","author":"MD Curley","year":"2009","unstructured":"Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R (2009) CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 27(12):2875\u20132883","journal-title":"Stem Cells"},{"issue":"4","key":"12_CR23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau W, Peng WC, Gros P, Clevers H (2014) The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28(4):305\u2013316","journal-title":"Genes Dev"},{"issue":"4","key":"12_CR24","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","volume":"5","author":"S Deng","year":"2010","unstructured":"Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang L-P, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, B\u00fctzow R, Coukos G, Zhang L (2010) Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5(4):e10277","journal-title":"PLoS One"},{"issue":"5","key":"12_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13402-013-0142-8","volume":"36","author":"J Di","year":"2013","unstructured":"Di J, Duiveman-de Boer T, Zusterzeel PLM, Figdor CG, Massuger LFAG, Torensma R (2013) The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cell Oncol (Dordr) 36(5):363\u2013374","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"12_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CBI20100347","volume":"35","author":"J Dou","year":"2011","unstructured":"Dou J, Jiang C, Wang J, Zhang X, Zhao F, Hu W, He X, Li X, Zou D, Gu N (2011) Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biol Int 35(3):227\u2013234","journal-title":"Cell Biol Int"},{"issue":"10","key":"12_CR27","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1007\/s13277-014-2277-2","volume":"35","author":"R Eyre","year":"2014","unstructured":"Eyre R, Harvey I, Stemke-Hale K, Lennard TWJ, Tyson-Capper A, Meeson AP (2014) Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population. Tumour Biol 35(10):9879\u20139892","journal-title":"Tumour Biol"},{"issue":"2","key":"12_CR28","doi-asserted-by":"crossref","first-page":"dju410","DOI":"10.1093\/jnci\/dju410","volume":"107","author":"H Falconer","year":"2015","unstructured":"Falconer H, Yin L, Gr\u00f6nberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst 107(2):dju410","journal-title":"J Natl Cancer Inst"},{"issue":"7716","key":"12_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation--a factor in ovarian neoplasia? Lancet 2(7716):163","journal-title":"Lancet"},{"issue":"3","key":"12_CR30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","volume":"18","author":"G Ferrandina","year":"2008","unstructured":"Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A, Zannoni G, Mancuso S, Scambia G (2008) Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 18(3):506\u2013514","journal-title":"Int J Gynecol Cancer"},{"key":"12_CR31","first-page":"763","volume-title":"Principles and practice of gynecologic oncology","author":"GF Fleming","year":"2009","unstructured":"Fleming GF, Ronnet BM, Seidman J, Zaino RJ, Rubin SC (2009) Epithelial ovarian cancer. In: Principles and practice of gynecologic oncology. Lippincott Williams & Wilkins, Philadelphia, pp 763\u2013837"},{"issue":"7440","key":"12_CR32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","volume":"495","author":"A Flesken-Nikitin","year":"2013","unstructured":"Flesken-Nikitin A, Hwang C-I, Cheng C-Y, Michurina TV, Enikolopov G, Nikitin AY (2013) Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495(7440):241\u2013245","journal-title":"Nature"},{"issue":"18","key":"12_CR33","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","volume":"29","author":"M-Q Gao","year":"2010","unstructured":"Gao M-Q, Choi Y-P, Kang S, Youn JH, Cho N-H (2010) CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29(18):2672\u20132680","journal-title":"Oncogene"},{"issue":"17","key":"12_CR34","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41388-017-0040-z","volume":"37","author":"D Ghannam-Shahbari","year":"2018","unstructured":"Ghannam-Shahbari D, Jacob E, Kakun RR, Wasserman T, Korsensky L, Sternfeld O, Kagan J, Bublik DR, Aviel-Ronen S, Levanon K, Sabo E, Larisch S, Oren M, Hershkovitz D, Perets R (2018) PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene 37(17):2213\u20132224","journal-title":"Oncogene"},{"issue":"17","key":"12_CR35","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1242\/dev.149989","volume":"144","author":"A Ghosh","year":"2017","unstructured":"Ghosh A, Syed SM, Tanwar PS (2017) In vivo genetic cell lineage tracing reveals that oviductal secretory cells self-renew and give rise to ciliated cells. Development 144(17):3031\u20133041","journal-title":"Development"},{"issue":"4","key":"12_CR36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","volume":"183","author":"MA Goodell","year":"1996","unstructured":"Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183(4):1797\u20131806","journal-title":"J Exp Med"},{"key":"12_CR37","doi-asserted-by":"publisher","unstructured":"Hatina J, Fernandes MI, Hoffmann MJ, Zeimet AG (2013) Cancer stem cells \u2013 basic biological properties and experimental approaches. Encyclopedia of Life Sciences. Chichester, John Wiley & Sons. https:\/\/doi.org\/10.1002\/9780470015902.a0021164.pub2","DOI":"10.1002\/9780470015902.a0021164.pub2"},{"issue":"6","key":"12_CR38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.bjc.6603003","volume":"94","author":"VA Heinzelmann-Schwarz","year":"2006","unstructured":"Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry JP, Scolyer RA, Smith AN, Bali A, Vanden Bergh P, Baron-Hay S, Scott C, Fink D, Hacker NF, Sutherland RL, O\u2019Brien PM (2006) A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br J Cancer 94(6):904\u2013913","journal-title":"Br J Cancer"},{"issue":"19","key":"12_CR39","first-page":"4550","volume":"53","author":"R Henriksen","year":"1993","unstructured":"Henriksen R, Funa K, Wilander E, B\u00e4ckstr\u00f6m T, Ridderheim M, Oberg K (1993) Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res 53(19):4550\u20134554","journal-title":"Cancer Res"},{"issue":"37","key":"12_CR40","doi-asserted-by":"crossref","first-page":"40310","DOI":"10.18632\/oncotarget.5643","volume":"6","author":"C Henry","year":"2015","unstructured":"Henry C, Llamosas E, Knipprath-M\u00e9sz\u00e1ros A, Schoetzau A, Obermann E, Fuenfschilling M, Caduff R, Fink D, Hacker N, Ward R, Heinzelmann-Schwarz V, Ford C (2015) Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget 6(37):40310\u201340326","journal-title":"Oncotarget"},{"issue":"1","key":"12_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(03)00110-4","volume":"16","author":"I Hornstein","year":"2004","unstructured":"Hornstein I, Alcover A, Katzav S (2004) Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16(1):1\u201311","journal-title":"Cell Signal"},{"issue":"1","key":"12_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13577-010-0002-z","volume":"24","author":"S Hosonuma","year":"2011","unstructured":"Hosonuma S, Kobayashi Y, Kojo S, Wada H, Seino K, Kiguchi K, Ishizuka B (2011) Clinical significance of side population in ovarian cancer cells. Hum Cell 24(1):9\u201312","journal-title":"Hum Cell"},{"issue":"8","key":"12_CR43","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","volume":"102","author":"L Hu","year":"2010","unstructured":"Hu L, McArthur C, Jaffe RB (2010) Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 102(8):1276\u20131283","journal-title":"Br J Cancer"},{"issue":"11","key":"12_CR44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/carcin\/bgv132","volume":"36","author":"H-S Huang","year":"2015","unstructured":"Huang H-S, Chu S-C, Hsu C-F, Chen P-C, Ding D-C, Chang M-Y, Chu T-Y (2015) Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis. Carcinogenesis 36(11):1419\u20131428","journal-title":"Carcinogenesis"},{"issue":"7","key":"12_CR45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neo.2017.03.002","volume":"19","author":"M Joglekar-Javadekar","year":"2017","unstructured":"Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL (2017) Characterization and targeting of platelet-derived growth factor receptor alpha (PDGFRA) in inflammatory breast cancer (IBC). Neoplasia 19(7):564\u2013573","journal-title":"Neoplasia"},{"issue":"5","key":"12_CR46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE (2011) The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 18(5):627\u2013642","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"12_CR47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2017.01.028","volume":"168","author":"LR Klug","year":"2017","unstructured":"Klug LR, Heinrich MC (2017) PDGFRA antibody for soft tissue sarcoma. Cell 168(4):555","journal-title":"Cell"},{"issue":"1","key":"12_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","volume":"130","author":"I Kryczek","year":"2012","unstructured":"Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W (2012) Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer 130(1):29\u201339","journal-title":"Int J Cancer"},{"issue":"4","key":"12_CR49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih I-M (2016) The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 186(4):733\u2013747","journal-title":"Am J Pathol"},{"issue":"6","key":"12_CR50","doi-asserted-by":"crossref","first-page":"e65158","DOI":"10.1371\/journal.pone.0065158","volume":"8","author":"T Kuroda","year":"2013","unstructured":"Kuroda T, Hirohashi Y, Torigoe T, Yasuda K, Takahashi A, Asanuma H, Morita R, Mariya T, Asano T, Mizuuchi M, Saito T, Sato N (2013) ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis. PLoS One 8(6):e65158","journal-title":"PLoS One"},{"issue":"17","key":"12_CR51","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E (2018) Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37(17):2285\u20132301","journal-title":"Oncogene"},{"issue":"12","key":"12_CR52","first-page":"936","volume":"44","author":"D-M Lai","year":"2009","unstructured":"Lai D-M, Liu T, Huang Y, Wang L-H, Zhang J, Cheng W-W (2009) Identification and characterization of ovarian cancer stem-like cells from primary tumor. Zhonghua Fu Chan Ke Za Zhi 44(12):936\u2013940","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"12","key":"12_CR53","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","volume":"9","author":"CN Landen","year":"2010","unstructured":"Landen CN, Goodman B, Katre AA, Steg AD, Nick AM, Stone RL, Miller LD, Mejia PV, Jennings NB, Gershenson DM, Bast RC, Coleman RL, Lopez-Berestein G, Sood AK (2010) Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 9(12):3186\u20133199","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"12_CR54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre G, Goranova TE, De Silva D, Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley L-A, Hanif A, Wilson C, Dowson S, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Paul J, Supernat A, Millan D, Hoyle A, Bryson G, Nourse C, Mincarelli L, Sanchez LN, Ylstra B, Jimenez-Linan M, Moore L, Hofmann O, Markowetz F, McNeish IA, Brenton JD (2018) Copy number signatures and mutational processes in ovarian carcinoma. Nat Genet 50(9):1262\u20131270","journal-title":"Nat Genet"},{"issue":"7","key":"12_CR55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng.3573","volume":"48","author":"A McPherson","year":"2016","unstructured":"McPherson A, Roth A, Laks E, Masud T, Bashashati A, Zhang AW, Ha G, Biele J, Yap D, Wan A, Prentice LM, Khattra J, Smith MA, Nielsen CB, Mullaly SC, Kalloger S, Karnezis A, Shumansky K, Siu C, Rosner J, Chan HL, Ho J, Melnyk N, Senz J, Yang W, Moore R, Mungall AJ, Marra MA, Bouchard-C\u00f4t\u00e9 A, Gilks CB, Huntsman DG, McAlpine JN, Aparicio S, Shah SP (2016) Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat Genet 48(7):758\u2013767","journal-title":"Nat Genet"},{"key":"12_CR56","first-page":"625","volume":"3","author":"K Mehra","year":"2011","unstructured":"Mehra K, Mehrad M, Ning G, Drapkin R, McKeon FD, Xian W, Crum CP (2011) STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front Biosci (Elite Ed) 3:625\u2013634","journal-title":"Front Biosci (Elite Ed)"},{"issue":"7","key":"12_CR57","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1073\/pnas.1120733109","volume":"109","author":"K Meirelles","year":"2012","unstructured":"Meirelles K, Benedict LA, Dombkowski D, Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin DT, Donahoe PK, Wei X (2012) Human ovarian cancer stem\/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proc Natl Acad Sci U S A 109(7):2358\u20132363","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"12_CR58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2011.10.006","volume":"124","author":"H Mitsui","year":"2012","unstructured":"Mitsui H, Shibata K, Suzuki S, Umezu T, Mizuno M, Kajiyama H, Kikkawa F (2012) Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination. Gynecol Oncol 124(2):303\u2013310","journal-title":"Gynecol Oncol"},{"issue":"14","key":"12_CR59","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1158\/0008-5472.CAN-07-6341","volume":"68","author":"L Moserle","year":"2008","unstructured":"Moserle L, Indraccolo S, Ghisi M, Frasson C, Fortunato E, Canevari S, Miotti S, Tosello V, Zamarchi R, Corradin A, Minuzzo S, Rossi E, Basso G, Amadori A (2008) The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. Cancer Res 68(14):5658\u20135668","journal-title":"Cancer Res"},{"issue":"40","key":"12_CR60","doi-asserted-by":"crossref","first-page":"64836","DOI":"10.18632\/oncotarget.11711","volume":"7","author":"PB Nagendra","year":"2016","unstructured":"Nagendra PB, Goad J, Nielsen S, Rassam L, Lombard JM, Nahar P, Tanwar PS (2016) Ovarian hormones through Wnt signalling regulate the growth of human and mouse ovarian cancer initiating lesions. Oncotarget 7(40):64836\u201364853","journal-title":"Oncotarget"},{"issue":"10","key":"12_CR61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrm4056","volume":"16","author":"A Ng","year":"2015","unstructured":"Ng A, Barker N (2015) Ovary and fimbrial stem cells: biology, niche and cancer origins. Nat Rev Mol Cell Biol 16(10):625\u2013638","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"12_CR62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ncb3000","volume":"16","author":"A Ng","year":"2014","unstructured":"Ng A, Tan S, Singh G, Rizk P, Swathi Y, Tan TZ, Huang RY-J, Leushacke M, Barker N (2014) Lgr5 marks stem\/progenitor cells in ovary and tubal epithelia. Nat Cell Biol 16(8):745\u2013757","journal-title":"Nat Cell Biol"},{"issue":"11","key":"12_CR63","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498\u20131503","journal-title":"Nat Med"},{"issue":"5","key":"12_CR64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3322\/canjclin.49.5.297","volume":"49","author":"EE Partridge","year":"1999","unstructured":"Partridge EE, Barnes MN (1999) Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 49(5):297\u2013320","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"12_CR65","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/onc.2009.500","volume":"29","author":"S Peng","year":"2010","unstructured":"Peng S, Maihle NJ, Huang Y (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29(14):2153\u20132159","journal-title":"Oncogene"},{"issue":"1","key":"12_CR66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","volume":"76","author":"R Perets","year":"2016","unstructured":"Perets R, Drapkin R (2016) It\u2019s totally tubular\u2026 riding the new wave of ovarian cancer research. Cancer Res 76(1):10\u201317","journal-title":"Cancer Res"},{"issue":"7","key":"12_CR67","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1349-7006.2012.02306.x","volume":"103","author":"D Pils","year":"2012","unstructured":"Pils D, Hager G, Tong D, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Cadron I, Mahner S, Hofstetter G, Speiser P, Zeillinger R (2012) Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium. Cancer Sci 103(7):1334\u20131341","journal-title":"Cancer Sci"},{"issue":"8","key":"12_CR68","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/ijc.31186","volume":"142","author":"D Reimer","year":"2018","unstructured":"Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG (2018) Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response. Int J Cancer 142(8):1640\u20131651","journal-title":"Int J Cancer"},{"key":"12_CR69","doi-asserted-by":"crossref","unstructured":"Roy L, Bobbs A, Sattler R, Kurkewich JL, Dausinas PB, Nallathamby P, Cowden Dahl KD (2018) CD133 promotes adhesion to the ovarian cancer metastatic niche.. Cancer Growth Metastasis 11:1179064418767882","DOI":"10.1177\/1179064418767882"},{"issue":"30","key":"12_CR70","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/onc.2012.363","volume":"32","author":"MKY Siu","year":"2013","unstructured":"Siu MKY, Wong ESY, Kong DSH, Chan HY, Jiang L, Wong OGW, Lam EW-F, Chan KKL, Ngan HYS, Le X-F, Cheung AN (2013) Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene 32(30):3500\u20133509","journal-title":"Oncogene"},{"issue":"30","key":"12_CR71","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A 103(30):11154\u201311159","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"12_CR72","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/path.5191","volume":"247","author":"TZ Tan","year":"2018","unstructured":"Tan TZ, Heong V, Ye J, Lim D, Low J, Choolani M, Scott C, Tan DSP, Huang RY-J (2018) Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer. J Pathol 247(3):305\u2013319. https:\/\/doi.org\/10.1002\/path.5191","journal-title":"J Pathol"},{"issue":"10043","key":"12_CR73","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0140-6736(16)30587-6","volume":"388","author":"WD Tap","year":"2016","unstructured":"Tap WD, Jones RL, Van Tine BA, Chmielowski B, Elias AD, Adkins D, Agulnik M, Cooney MM, Livingston MB, Pennock G, Hameed MR, Shah GD, Qin A, Shahir A, Cronier DM, Ilaria R, Conti I, Cosaert J, Schwartz GK (2016) Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet 388(10043):488\u2013497","journal-title":"Lancet"},{"issue":"27","key":"12_CR74","doi-asserted-by":"crossref","first-page":"44312","DOI":"10.18632\/oncotarget.17871","volume":"8","author":"S Tayama","year":"2017","unstructured":"Tayama S, Motohara T, Narantuya D, Li C, Fujimoto K, Sakaguchi I, Tashiro H, Saya H, Nagano O, Katabuchi H (2017) The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer. Oncotarget 8(27):44312\u201344325","journal-title":"Oncotarget"},{"issue":"4","key":"12_CR75","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gmit.2017.08.003","volume":"6","author":"P-L Torng","year":"2017","unstructured":"Torng P-L (2017) Clinical implication for endometriosis associated with ovarian cancer. Gynecol Minim Invasive Ther 6(4):152\u2013156","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"18","key":"12_CR76","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/MCB.00202-16","volume":"36","author":"Y Wang","year":"2016","unstructured":"Wang Y, Cai KQ, Smith ER, Yeasky TM, Moore R, Ganjei-Azar P, Klein-Szanto AJ, Godwin AK, Hamilton TC, Xu X-X (2016) Follicle depletion provides a permissive environment for ovarian carcinogenesis. Mol Cell Biol 36(18):2418\u20132430","journal-title":"Mol Cell Biol"},{"issue":"44","key":"12_CR77","doi-asserted-by":"crossref","first-page":"18874","DOI":"10.1073\/pnas.1012667107","volume":"107","author":"X Wei","year":"2010","unstructured":"Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT, Donahoe PK (2010) Mullerian inhibiting substance preferentially inhibits stem\/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci U S A 107(44):18874\u201318879","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"12_CR78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/cas.13186","volume":"108","author":"Y Wen","year":"2017","unstructured":"Wen Y, Hou Y, Huang Z, Cai J, Wang Z (2017) SOX2 is required to maintain cancer stem cells in ovarian cancer. Cancer Sci 108(4):719\u2013731","journal-title":"Cancer Sci"},{"issue":"2","key":"12_CR79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/onc.2013.537","volume":"34","author":"T Xiang","year":"2015","unstructured":"Xiang T, Long H, He L, Han X, Lin K, Liang Z, Zhuo W, Xie R, Zhu B (2015) Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer. Oncogene 34(2):165\u2013176","journal-title":"Oncogene"},{"issue":"22","key":"12_CR80","first-page":"3497","volume":"18","author":"HC Yan","year":"2014","unstructured":"Yan HC, Fang LS, Xu J, Qiu YY, Lin XM, Huang HX, Han QY (2014) The identification of the biological characteristics of human ovarian cancer stem cells. Eur Rev Med Pharmacol Sci 18(22):3497\u20133503","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"12_CR81","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3892\/ol.2015.2971","volume":"9","author":"HC Yan","year":"2015","unstructured":"Yan HC, Xu J, Fang LS, Qiu YY, Lin XM, Huang HX, Han QY (2015) Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells. Oncol Lett 9(4):1614\u20131620","journal-title":"Oncol Lett"},{"issue":"6","key":"12_CR82","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4149\/neo_2012_094","volume":"59","author":"AG Zeimet","year":"2012","unstructured":"Zeimet AG, Reimer D, Sopper S, Boesch M, Martowicz A, Roessler J, Wiedemair AM, Rumpold H, Untergasser G, Concin N, Hofstetter G, Muller-Holzner E, Fiegl H, Marth C, Wolf D, Pesta M, Hatina J (2012) Ovarian cancer stem cells. Neoplasma 59(6):747\u2013755","journal-title":"Neoplasma"},{"issue":"11","key":"12_CR83","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai H-C, Matei D, Schilder JM, Yan PS, Huang TH-M, Nephew KP (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68(11):4311\u20134320","journal-title":"Cancer Res"},{"issue":"48","key":"12_CR84","doi-asserted-by":"crossref","first-page":"17266","DOI":"10.1073\/pnas.1419599111","volume":"111","author":"S Zhang","year":"2014","unstructured":"Zhang S, Cui B, Lai H, Liu G, Ghia EM, Widhopf GF, Zhang Z, Wu CCN, Chen L, Wu R, Schwab R, Carson DA, Kipps TJ (2014) Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Proc Natl Acad Sci U S A 111(48):17266\u201317271","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"12_CR86","first-page":"153","volume":"65","author":"Q-H Zhang","year":"2015","unstructured":"Zhang Q-H, Dou H-T, Xu P, Zhuang S-C, Liu P-S (2015) Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer. Drug Res (Stuttg) 65(3):153\u2013157","journal-title":"Drug Res (Stuttg)"},{"issue":"2","key":"12_CR87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/IGC.0000000000001171","volume":"28","author":"M Zhang","year":"2018","unstructured":"Zhang M, Liu T, Xia B, Yang C, Hou S, Xie W, Lou G (2018) Platelet-derived growth factor d is a prognostic biomarker and is associated with platinum resistance in epithelial ovarian cancer. Int J Gynecol Cancer 28(2):323\u2013331","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"12_CR88","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","volume":"11","author":"KK Zorn","year":"2005","unstructured":"Zorn KK, Bonome T, Gangi L, Chandramouli GVR, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ (2005) Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11(18):6422\u20136430","journal-title":"Clin Cancer Res"}],"container-title":["Advances in Experimental Medicine and Biology","Stem Cells Heterogeneity in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-14366-4_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T17:46:01Z","timestamp":1663523161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-14366-4_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030143657","9783030143664"],"references-count":89,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-14366-4_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"28 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}